INMUNE BIO INC. Gain (Loss) Related to Litigation Settlement
INMUNE BIO INC. (INMB) reported Gain (Loss) Related to Litigation Settlement of $150.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2019-03-29
- INMUNE BIO INC. gain (loss) related to litigation settlement for fiscal 2017 was $150.00K.
| Period end | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|
| 2017-12-31 | $150.00K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |